Active

Sheridan Capital Partners

General contacts

Investor type

PE / VC

Founded

2012

AUM

$1 000 M

Location

Chicago, Illinois, United States

Investment Ticket

$10-50 m

Investment Stage

Pre-seed Seed Series A Series B Late Stage (Series C+)

Region of investment

North America

Investor profile last updated: 09 October, 2026

Profile

Sheridan Capital Partners is a private equity firm based in Chicago, Illinois, founded by Jonathan Lewis and Sean Dempsey. Specializing in healthcare investments, the firm is noted for its focus on outsourced services, product and manufacturing, and patient services. Sheridan differentiates itself through a deep industry focus and strategic partnership approach, helping management teams optimize for growth and value creation.

Sheridan's investment themes revolve around healthcare, particularly targeting sectors with positive secular trends. They invest across outsourced services, healthcare IT, healthcare providers, and related technology. Their typical investment size is $10-50 million, focusing on Series A through late-stage deals. The firm's funds include Fund IV at $1.1 billion and the new Healthcare IT Fund I at $245 million, targeting North America. Total assets under management exceed $2.4 billion.

Notable portfolio companies within Sheridan's funds include Smile Doctors - orthodontics services, SpendMend - hospital cost-saving solutions, Diamondback Drugs - specialty veterinary pharmacy, Carolina Components Group, Tres Health, and Currier Plastics. These investments highlight Sheridan's distinct focus on healthcare across multiple subsectors.

Industry

SaaS Medical Devices Healthcare Services Food and Beverage Fintech Financial Services HealthTech MedTech Software Business Services (B2B) Foodtech

Sheridan Capital Partners Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
Sheridan Legacy Fund I	Private Equity (PE)	Financial Services Fintech Food and Beverage Foodtech Healthcare Services	Series B Late Stage (Series C+)	North America	$5-10 m	$150 M	October 2012
Sheridan Capital Partners Fund III, LP	Private Equity (PE)	Financial Services Fintech Food and Beverage Foodtech Healthcare Services	Series B Late Stage (Series C+)	North America	$5-10 m	$575 M	June 2023
Sheridan Capital Partners Fund IV	Private Equity (PE)	Healthcare Services Medical Devices MedTech	Series A Series B Late Stage (Series C+)	North America	$10-50 m	$1100 M	October 2026

Contacts

Name

Title

Social Networks

Conor H. Kolstad Vice President

Vice President

c•••@•••

Stephen R. Lestyan Vice President

Vice President

s•••@•••

Upgrade to see contacts

VGhMPBTIE7Wbn4dz VGhMPBTIE7Wbn4dz

VGhMPBTIE7Wbn4dz

[email protected]

VGhMPBTIE7Wbn4dz VGhMPBTIE7Wbn4dz

VGhMPBTIE7Wbn4dz

[email protected]

VGhMPBTIE7Wbn4dz VGhMPBTIE7Wbn4dz

VGhMPBTIE7Wbn4dz

[email protected]

Investment-team contacts for Sheridan Capital Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Sheridan Capital Partners

Is Sheridan Capital Partners a venture capital or private equity firm?

Sheridan Capital Partners is a venture capital and private equity firm. It backs companies at Pre-seed, Seed, Series A, Series B and Late Stage (Series C+), writing tickets of $10-50 m.

Where is Sheridan Capital Partners located?

Sheridan Capital Partners is located in Chicago, Illinois, United States.

When was Sheridan Capital Partners founded?

Sheridan Capital Partners was founded in 2012.

What sectors and industries does Sheridan Capital Partners invest in?

Sheridan Capital Partners invests in companies and startups in SaaS, Medical Devices, Healthcare Services, Food and Beverage, Fintech, Financial Services, HealthTech, MedTech, Software, Business Services (B2B), Foodtech.

What is Sheridan Capital Partners geographical focus of investments?

Sheridan Capital Partners invests in companies and startups in North America.

At what stages of companies and startups does Sheridan Capital Partners typically invest in?

Sheridan Capital Partners invests in companies and startups at Pre-seed, Seed, Series A, Series B, Late Stage (Series C+).

What is the usual amount of Sheridan Capital Partners investment?

Sheridan Capital Partners usually invests $10-50 m on average.

What is the amount of assets of under management (AUM) for Sheridan Capital Partners?

Sheridan Capital Partners has around $1 000m assets under management.

When was Sheridan Capital Partners last fund created?

Sheridan Capital Partners last fund was created/launched in 2026-10-08

What are the contacts of Sheridan Capital Partners?

Sheridan Capital Partners can be reached through its website sheridancp.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Sheridan Capital Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Sheridan Capital Partners data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Sheridan Capital Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Sheridan Capital Partners profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 09 October, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.